Amyotrophic Lateral Sclerosis: all 1,000 studies
Page 9 of 10. Open to participants first (284), then studies with results posted, then the rest; newest registration first within each.
- A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis LateralCompletedNCT02290886Phase 1/2
- Intramuscular Infusion of Autologous Bone Marrow Stem Cells in Patients With Amyotrophic Lateral SclerosisStatus unknownNCT02286011Phase 1
- A follow-on Study to Assess Long-term Safety and Tolerability of i.c.v Administration of sNN0029 in Patients With ALSTerminatedNCT02269436Phase 1
- Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral SclerosisWithdrawnNCT02242071Phase 1
- PET Imaging in ALS PatientsCompletedNCT02236897Not applicable
- Combination Therapy of Cord Blood and G-CSF for Patients With Brain Injury or Neurodegenerative DisordersCompletedNCT02236065Not applicable
- Analysis of Post-Translational Modifications of a Critical Protein Implicated in Amyotrophic Lateral SclerosisCompletedNCT02228915
- Biological Treatment of Amyotrophic Lateral SclerosisStatus unknownNCT02193893Phase 1
- Tamoxifen Treatment in Patients With Motor Neuron DiseaseCompletedNCT02166944Phase 1/2
- Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) PatientsCompletedNCT02164253Phase 2
- Oral Nutritional Supplementation in Amyotrophic Lateral Sclerosis (ALS) PatientsCompletedNCT02152449Not applicable
- Study of Hepatic Function in Patients With Spinal and Bulbar Muscular AtrophyCompletedNCT02124057
- Innovative Measures of Speech and Swallowing Dysfunction in Neurological DisordersCompletedNCT02118805
- Mesenchymal Stem Cell Injection in Amyotrophic Lateral SclerosisWithdrawnNCT02116634Phase 1/2
- Innovative Ultrasound Technology in Neuromuscular DiseaseCompletedNCT02104921
- Immuno-modulation in Amyotrophic Lateral Sclerosis- a Phase II Study of Safety and Activity of Low Dose Interleukin-2CompletedNCT02059759Phase 2
- Therapeutic Imaging Biomarkers for Amyotrophic Lateral SclerosisTerminatedNCT02058732Not applicable
- Study of Electrical Impedance Myography (EIM) in ALSCompletedNCT02011204
- Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)TerminatedNCT02000713Not applicable
- A Safety Study of sNN0029 Administration Via Intracerebroventricular Route to Patients With ALSTerminatedNCT01999803Phase 1
- Developing a Discrimination Model to Diagnose ALSCompletedNCT01995903Not applicable
- Study of miRNA Expression Pattern as Diagnostic and Prognostic Biomarker in Amyotrophic Lateral SclerosisTerminatedNCT01992029
- Stem Cell Therapy for Amyotrophic Lateral SclerosisWithdrawnNCT01984814Phase 2
- Dysfunctions and Plasticity Mechanisms of Motor System Assessed by Cortico-cortical and Cortico-muscular Coherence Analysis in Amyotrophic Lateral SclerosisSuspendedNCT01959373Not applicable
- Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative DiseasesWithdrawnNCT01954875
- LIME Study (LFB IVIg MMN Efficacy Study)CompletedNCT01951924Phase 3
- Establishment of a Tissue Bank (Blood, CSF) for the Understanding of Motor Neuron Disease (MND)TerminatedNCT01950910
- Identification of Diagnostic And Prognostic Biomarkers From Amyotrophic Lateral Sclerosis (ALS) Skin and Adipose SamplesCompletedNCT01948102
- Magnetic Resonance Imaging (MRI) in Amyotrophic Lateral Sclerosis (ALS)WithdrawnNCT01945853Not applicable
- Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01938495Phase 2
- A Clinical Trial of Safety and Efficacy of Fasudil in Subjects With Amyotrophic Lateral Sclerosis (ALS)Status unknownNCT01935518Phase 2
- Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01933321Phase 2/3
- Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene MutationCompletedNCT01925196
- Longitudinal Study of Outcomes Measures in ALS TrialsCompletedNCT01911130
- Communication by Brain - Computer Interface in Amyotrophic Lateral Sclerosis:Feasibility StudyStatus unknownNCT01897818Not applicable
- Monitoring of Non-invasive Ventilation During Sleep in ALSCompletedNCT01889043
- Study of Rasagiline in Patients With Amyotrophic Lateral SclerosisCompletedNCT01879241Phase 2
- From Movement Preparation to Gait Execution in ALSCompletedNCT01874808
- GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)CompletedNCT01854294Phase 2
- Determining the Safety of L-serine in ALSStatus unknownNCT01835782Phase 1/2
- The Effect of GCSF in the Treatment of ALS PatientsCompletedNCT01825551Phase 2/3
- Influence of the Vitamin D Blood Levels on the Amyotrophic Lateral Sclerosis PhenotypeCompletedNCT01823380Not applicable
- Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance MyographyCompletedNCT01803386
- Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01777646Phase 2
- Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron DiseaseCompletedNCT01776970Phase 2/3
- Chewing Efficiency Measured by a Two Colour Chewing Gum Test in Amyotrophic Lateral Sclerosis (ALS) Patients?CompletedNCT01772888
- Intrathecal Transplantation of Mesenchymal Stem Cell in Patients With ALSCompletedNCT01771640Phase 1
- Intravenous Transplantation of Mesenchymal Stem Cell in Patients With ALSCompletedNCT01759797Phase 1
- Intraventricular Transplantation of Mesenchymal Stem Cell in Patients With ALSWithdrawnNCT01759784Phase 1
- Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral SclerosisCompletedNCT01758510Phase 1
- Non-invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Using the iVAPS ModeCompletedNCT01746381Not applicable
- Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral SclerosisStatus unknownNCT01730716Phase 2
- DNA, Blood and Skin Cell Repository for Research on ALS and Related Neurodegenerative Disorders at Mayo Clinic FloridaCompletedNCT01699451
- Aerobic Exercise Training in Amyotrophic Lateral SclerosisStatus unknownNCT01650818Not applicable
- Impact of Early Non Invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) PatientsCompletedNCT01641965Not applicable
- Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01640067Phase 1
- Creation of a Bank of Fibroblast From Patients With Amyotrophic Lateral Sclerosis: Pilot StudyCompletedNCT01639391Not applicable
- A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral SclerosisCompletedNCT01609283Phase 1
- Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral SclerosisCompletedNCT01605006Not applicable
- A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker DiscoveryCompletedNCT01592552
- Hyperlipidemia and Statin Therapy in Amyotrophic Lateral SclerosisCompletedNCT01592084
- Early Stage Amyotrophic Lateral Sclerosis Phrenic StimulationTerminatedNCT01583088Phase 3
- Transcranial Direct Current Stimulation as a Novel Therapeutic Approach in Amyotrophic Lateral SclerosisStatus unknownNCT01569958Phase 2
- Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)WithdrawnNCT01565395Phase 2
- Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related SialorrheaCompletedNCT01551940Phase 2
- Dexpramipexole and Cimetidine Drug Drug Interaction (DDI)CompletedNCT01536249Phase 1
- Study of Cognitive and Emotional Disorders in Amyotrophic Lateral SclerosisStatus unknownNCT01530438Not applicable
- Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01521728Not applicable
- Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)CompletedNCT01511029Phase 1
- PRE-Symptomatic Studies in Amyotrophic Lateral SclerosisActive, not recruitingNCT01508962
- Muscle Training of Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01504009Not applicable
- A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) BiomarkersCompletedNCT01495390
- The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral SclerosisStatus unknownNCT01494480Phase 2
- Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01486849Phase 2
- Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular DisordersWithdrawnNCT01459302
- Dexpramipexole SAD/MAD StudyCompletedNCT01449578Phase 1
- Dexpramipexole Renal PK StudyCompletedNCT01424176Phase 1
- Dexpramipexole Japanese PK StudyCompletedNCT01424163Phase 1
- An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral SclerosisTerminatedNCT01384162Phase 1/2
- A Study to Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01378676Phase 2
- Study of the Role of G72 in Amyotrophic Lateral Sclerosis: Biomarker Discovery and Mechanism InvestigationStatus unknownNCT01378026
- Effect of Functional Exercise in Patients With Spinal Bulbar Muscular AtrophyCompletedNCT01369901Phase 1/2
- PRISM Registry: Pseudobulbar Affect Registry SeriesCompletedNCT01366027
- Polysomnography-directed Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT01363882Not applicable
- Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral SclerosisStatus unknownNCT01348451Phase 1
- Safety Extension Study of TRO19622 in ALSCompletedNCT01285583Phase 2/3
- A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01281631Phase 2
- Safety and Tolerability of Anakinra in Combination With Riluzol in Amyotrophic Lateral SclerosisCompletedNCT01277315Phase 2
- Safety Study of High Doses of Zinc in ALS PatientsCompletedNCT01259050Phase 1/2
- Clinical Trial on The Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis (Extension CMN/ELA)CompletedNCT01254539Phase 1/2
- Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-LifeCompletedNCT01160367Not applicable
- Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and ControlsCompletedNCT01160263Phase 3
- Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01142856Phase 1
- Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01091142Phase 1
- Relationship Between Respiratory Functional Tests and Image Thoracic Techniques in Patients With Neuromuscular DiseasesCompletedNCT01090674
- A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01089010Phase 2
- Safety/Efficacy Study for the Treatment of Amyotrophic Lateral SclerosisSuspendedNCT01082653Phase 1
- Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients.CompletedNCT01051882Phase 1/2
- Safety, Tolerability, and Activity Study of ISIS SOD1Rx to Treat Familial Amyotrophic Lateral Sclerosis (ALS) Caused by SOD1 Gene MutationsCompletedNCT01041222Phase 1
- Memantine Therapy in Amyotrophic Lateral SclerosisCompletedNCT01020331Phase 2